Concepedia

Heng-Wei Liu

HL

Statistics

Publications

2

Citations

120

H-Index

2

Active since

2018

Affiliations

Taipei Medical University(Current)

Taipei Medical University-Shuang Ho Hospital

Heng-Wei Liu is an author at Taipei Medical University specializing in oncology, glioblastoma, and stat3 signaling.

Publications per year

2018–2019

2

Publications

2

Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages

Hao-Yu Chuang, Yu-Kai Su, Heng-Wei Liu et al. · Journal of Clinical Medicine · 2019 · 88 citations · Full text

, , +17

The Disruption of the β-Catenin/TCF-1/STAT3 Signaling Axis by 4-Acetylantroquinonol B Inhibits the Tumorigenesis and Cancer Stem-Cell-Like Properties of Glioblastoma Cells, In Vitro and In Vivo

Heng-Wei Liu, Yu-Kai Su, Oluwaseun Adebayo Bamodu et al. · Cancers · 2018 · 32 citations · Full text

, , +17

1–2 of 2